[1]
“Small molecules in idiopathic inflammatory myopathies: a systematic review and a multicenter case series about Janus kinase inhibitors and apremilast”, Reumatismo, vol. 77, no. 2, Jan. 2025, doi: 10.4081/reumatismo.2025.1718.